Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
- Sponsor
- Changhua Christian Hospital
- Study ID
- NCT03897192
- Status
- Completed
Conditions
- Punctate Inner Choroidopathy
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab — DRUGAnti-vascular endothelial growth factor (VEGF)
Study Details
To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).
Key Dates
- First listed
- Apr 1, 2019
- Start date
- Oct 1, 2018
- Status verified
- Mar 2019
- Primary completion
- Jan 31, 2019
- Completion
- Mar 20, 2019
Study Design
- Enrollment
- 14 participants (actual)
Primary Outcome Measure
Wilcoxon Signed-Rank test [ Time Frame: Baseline, 4 year ]